Condition: Gastrointestinal Neoplasm Malignant · Sponsor: Chinese Academy of Sciences
This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
This description comes directly from the study's public registry record.
Di Dong, PhD · +86 13811833760 · di.dong@ia.ac.cn
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Not Yet Recruiting |
| Jiangmen Central Hospital | Jiangmen, Guangdong, China | Recruiting |
| The Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai, Guangdong, China | Recruiting |
| Zhuhai People's Hospital | Zhuhai, Guangdong, China | Recruiting |
| Peking University Cancer Hospital (Inner Mongolia Campus) | Hohhot, Inner Mongolia, China | Recruiting |
| University Hospital Magdeburg | Magdeburg, Saxony-Anhalt, Germany | Not Yet Recruiting |
| San Raffaele University Hospital, Italy | Milan, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06002425